24. Gunalan K, Niangaly A, Thera MA, Doumbo OK, Miller LH. Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation? Trends in parasitology. 2018; 34 (5):420-9. Epub 2018/03/14. https://doi.org/10.1016/j.pt.2018.02.006 PMID: 29530446; PubMed Central PMCID: PMC6347384.

25. Lo E, Hostetler JB, Yewhalaw D, Pearson RD, Hamid MMA, Gunalan K, et al. Frequent expansion of Plasmodium vivax Duffy Binding Protein in Ethiopia and its epidemiological significance. PLoS neglected tropical diseases. 2019; 13(9):e0007222. Epub 2019/09/12. https://doi.org/10.1371/journal.pntd.0007222 PMID: 31509523.

26. Cowman AF, Tonkin CJ, Tham WH, Duraisingh MT. The Molecular Basis of Erythrocyte Invasion by Malaria Parasites. Cell host & microbe. 2017; 22(2):232-45. Epub 2017/08/12. https://doi.org/10.1016/j.chom.2017.07.003 PMID: 28799908.

27. Gruszczyk J, Kanjee U, Chan LJ, Menant S, Malleret B, Lim NTY, et al. Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax. Science (New York, NY. 2018; 359(6371):48-55. Epub 2018/01/06. https://doi.org/10.1126/science.aan1078 PMID: 29302006; PubMed Central PMCID: PMC5788258.

28. Cheng Y, Lu F, Wang B, Li J, Han JH, Ito D, et al. Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status. Scientific reports. 2016; 6:35581. Epub 2016/10/21. https://doi.org/10.1038/srep35581 PMID: 27759110; PubMed Central PMCID: PMC5069673.

29. Ntumngia FB, Thomson-Luque R, Torres Lde M, Gunalan K, Carvalho LH, Adams JH. A Novel Erythrocyte Binding Protein of Plasmodium vivax Suggests an Alternate Invasion Pathway into Duffy-Positive Reticulocytes. mBio. 2016; 7(4). Epub 2016/08/25. https://doi.org/10.1128/mBio.01261-16 PMID: 27555313; PubMed Central PMCID: PMC4999553.

30. Bustamante LY, Powell GT, Lin YC, Macklin MD, Cross N, Kemp A, et al. Synergistic malaria vaccine combinations identified by systematic antigen screening. Proceedings of the National Academy of Sciences of the United States of America. 2017; 114(45):12045-50. Epub 2017/10/29. https://doi.org/10.1073/pnas.1702944114 PMID: 29078270; PubMed Central PMCID: PMC5692528.

31. Hostetler JB, Sharma S, Bartholdson SJ, Wright GJ, Fairhurst RM, Rayner JC. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions. PLoS neglected tropical diseases. 2015; 9(12):e0004264. https://doi.org/10.1371/journal.pntd.0004264 PMID: 26701602; PubMed Central PMCID: PMC4689532.

32. Malleret B, Li A, Zhang R, Tan KS, Suwanarusk R, Claser C, et al. Plasmodium vivax: restricted tropism and rapid remodeling of CD71-positive reticulocytes. Blood. 2015; 125(8):1314-24. Epub 2014/11/22. https://doi.org/10.1182/blood-2014-08-596015 PMID: 25414440; PubMed Central PMCID: PMC4401350.

33. Golenda CF, Li J, Rosenberg R. Continuous in vitro propagation of the malaria parasite Plasmodium vivax. Proceedings of the National Academy of Sciences of the United States of America. 1997; 94 (13):6786-91. Epub 1997/06/24. https://doi.org/10.1073/pnas.94.13.6786 PMID: 9192643; PubMed Central PMCID: PMC21236.

34. Udomsangpetch R, Somsri S, Panichakul T, Chotivanich K, Sirichaisinthop J, Yang Z, et al. Short-term in vitro culture of field isolates of Plasmodium vivax using umbilical cord blood. Parasitology international. 2007; 56(1):65-9. Epub 2007/01/27. https://doi.org/10.1016/j.parint.2006.12.005 PMID: 17254835.

35. Udomsangpetch R, Kaneko O, Chotivanich K, Sattabongkot J. Cultivation of Plasmodium vivax. Trends in parasitology. 2008; 24(2):85-8. Epub 2008/01/09. https://doi.org/10.1016/j.pt.2007.09.010 PMID: 18180202.

36. Panichakul T, Sattabongkot J, Chotivanich K, Sirichaisinthop J, Cui L, Udomsangpetch R. Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. International journal for parasitology. 2007; 37(14):1551-7. Epub 2007/07/06. https://doi.org/10.1016/j.ijpara.2007.05.009 PMID: 17610880.

37. Scully EJ, Shabani E, Rangel GW, Gruring C, Kanjee U, Clark MA, et al. Generation of an immortalized erythroid progenitor cell line from peripheral blood: A model system for the functional analysis of Plasmodium spp. invasion. Am J Hematol. 2019; 94(9):963-74. Epub 2019/05/31. https://doi.org/10.1002/ajh.25543 PMID: 31148215; PubMed Central PMCID: PMC6984401.

38. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008; 455(7214):757-63. Epub 2008/10/10. nature07327 [pii] https://doi.org/10.1038/nature07327 PMID: 18843361; PubMed Central PMCID: PMC2651158.

39. Rutledge GG, Bohme U, Sanders M, Reid AJ, Cotton JA, Maiga-Ascofoare O, et al. Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution. Nature. 2017; 542
(7639):101–4. Epub 2017/01/25. https://doi.org/10.1038/nature21038 PMID: 28117441; PubMed Central PMCID: PMC5326575.

40. Moon RW, Hall J, Rangkuti F, Ho YS, Almond N, Mitchell GH, et al. Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(2):531–6. Epub 2012/12/26. https://doi.org/10.1073/pnas.1216457110 PMID: 23267069; PubMed Central PMCID: PMC3545754.

41. Lim C, Hansen E, DeSimone TM, Moreno Y, Junker K, Bei A, et al. Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans. Nat Commun. 2013; 4:1638. Epub 2013/03/29. https://doi.org/10.1038/ncomms2612 PMID: 23535659; PubMed Central PMCID: PMC3762474.

42. Muh F, Lee SK, Hoque MR, Han JH, Park JH, Firdaus ER, et al. In vitro invasion inhibition assay using antibodies against Plasmodium knowlesi Duffy binding protein alpha and apical membrane antigen protein 1 in human erythrocyte-adapted P. knowlesi A1-H.1 strain. Malaria journal. 2018; 17(1):272. Epub 2018/07/28. https://doi.org/10.1186/s12936-018-2420-4 PMID: 30049277; PubMed Central PMCID: PMC6062950.

43. Muh F, Kim N, Nyunt MH, Firdaus ER, Han JH, Hoque MR, et al. Cross-species reactivity of antibodies against Plasmodium vivax blood-stage antigens to Plasmodium knowlesi. PLoS neglected tropical diseases. 2020; 14(6):e0008323. Epub 2020/06/20. https://doi.org/10.1371/journal.pntd.0008323 PMID: 32559186; PubMed Central PMCID: PMC7304578.

44. Moon RW, Sharaf H, Hastings CH, Ho YS, Nair MB, Rchiad Z, et al. Normocyte-binding protein required for human erythrocyte invasion by the zoonotic malaria parasite Plasmodium knowlesi. Proceedings of the National Academy of Sciences of the United States of America. 2016; 113(26):7231–6. https://doi.org/10.1073/pnas.1522469113 PMID: 27303038; PubMed Central PMCID: PMC4933575.

45. Knuepfer E, Wright KE, Kumar Prajapati S, Rawlinson TA, Mohring F, Koch M, et al. Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites. PLoS Pathog. 2019; 15(6):e1007809. Epub 2019/06/12. https://doi.org/10.1371/journal.ppat.1007809 PMID: 31185066; PubMed Central PMCID: PMC6588255.

46. Mohring F, Hart MN, Rawlinson TA, Henrici R, Charleston JA, Diez Benavente E, et al. Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research. eLife. 2019;8. Epub 2019/06/18. https://doi.org/10.7554/eLife.45829 PMID: 31205002; PubMed Central PMCID: PMC6579517.

47. Rawlinson TA, Barber NM, Mohring F, Cho JS, Kosaisavee V, Gerard SF, et al. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody. Nat Microbiol. 2019; 4(9):1497–507. Epub 2019/05/28. https://doi.org/10.1038/s41564-019-0462-1 PMID: 31133755; PubMed Central PMCID: PMC6711757.

48. Crosnier C, Wanaguru M, McDade B, Osier FH, Marsh K, Rayner JC, et al. A library of functional recombinant cell surface and secreted Plasmodium falciparum merozoite proteins. Molecular & cellular proteomics: MCP. 2013. Epub 2013/09/18. https://doi.org/10.1074/mcp.O113.028357 PMID: 24043421.

49. Bustamante LY, Bartholdson SJ, Crosnier C, Campos MG, Wanaguru M, Nguon C, et al. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants. Vaccine. 2013; 31(2):373–9. Epub 2012/11/14. https://doi.org/10.1016/j.vaccine.2012.10.106 PMID: 23146673; PubMed Central PMCID: PMC3538003.

50. Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2008; 46(2):165–71. Epub 2008/01/04. https://doi.org/10.1086/524888 PMID: 18171245; PubMed Central PMCID: PMC2533694.

51. Douglas AD, Williams AR, Illingworth JJ, Kamuyu G, Biswas S, Goodman AL, et al. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun. 2011; 2:601. Epub 2011/12/22. https://doi.org/10.1038/ncomms1615 PMID: 22186897.

52. Douglas AD, Baldeviano GC, Lucas CM, Lugo-Roman LA, Crosnier C, Bartholdson SJ, et al. A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys. Cell host & microbe. 2015; 17(1):130–9. https://doi.org/10.1016/j.chom.2014.11.017 PMID: 25590760; PubMed Central PMCID: PMC4297294.

53. Payne RO, Silk SE, Elias SC, Miura K, Diouf A, Galaway F, et al. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. JCI Insight. 2017; 2(21). Epub 2017/11/03. https://doi.org/10.1172/jci.insight.96381 PMID: 29093263; PubMed Central PMCID: PMC5752323.

54. Singh AP, Ozwara H, Kocken CH, Puri SK, Thomas AW, Chitnis CE. Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion. Molecular microbiology. 2005; 55(6):1925–34. Epub 2005/03/09. https://doi.org/10.1111/j.1365-2958.2005.04523.x PMID: 15752210.
(7639):101–4. Epub 2017/01/25. https://doi.org/10.1038/nature21038 PMID: 28117441; PubMed Central PMCID: PMC5326575.

40. Moon RW, Hall J, Rangkuti F, Ho YS, Almond N, Mitchell GH, et al. Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(2):531–6. Epub 2012/12/26. https://doi.org/10.1073/pnas.1216457110 PMID: 23267069; PubMed Central PMCID: PMC3545754.

41. Lim C, Hansen E, DeSimone TM, Moreno Y, Junker K, Bei A, et al. Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans. Nat Commun. 2013; 4:1638. Epub 2013/03/29. https://doi.org/10.1038/ncomms2612 PMID: 23535659; PubMed Central PMCID: PMC3762474.

42. Muh F, Lee SK, Hoque MR, Han JH, Park JH, Firdaus ER, et al. In vitro invasion inhibition assay using antibodies against Plasmodium knowlesi Duffy binding protein alpha and apical membrane antigen protein 1 in human erythrocyte-adapted P. knowlesi A1-H.1 strain. Malaria journal. 2018; 17(1):272. Epub 2018/07/28. https://doi.org/10.1186/s12936-018-2420-4 PMID: 30049277; PubMed Central PMCID: PMC6062950.

43. Muh F, Kim N, Nyunt MH, Firdaus ER, Han JH, Hoque MR, et al. Cross-species reactivity of antibodies against Plasmodium vivax blood-stage antigens to Plasmodium knowlesi. PLoS neglected tropical diseases. 2020; 14(6):e0008323. Epub 2020/06/20. https://doi.org/10.1371/journal.pntd.0008323 PMID: 32559186; PubMed Central PMCID: PMC7304578.

44. Moon RW, Sharaf H, Hastings CH, Ho YS, Nair MB, Rchiad Z, et al. Normocyte-binding protein required for human erythrocyte invasion by the zoonotic malaria parasite Plasmodium knowlesi. Proceedings of the National Academy of Sciences of the United States of America. 2016; 113(26):7231–6. https://doi.org/10.1073/pnas.1522469113 PMID: 27303038; PubMed Central PMCID: PMC4933575.

45. Knuepfer E, Wright KE, Kumar Prajapati S, Rawlinson TA, Mohring F, Koch M, et al. Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites. PLoS Pathog. 2019; 15(6):e1007809. Epub 2019/06/12. https://doi.org/10.1371/journal.ppat.1007809 PMID: 31185066; PubMed Central PMCID: PMC6588255.

46. Mohring F, Hart MN, Rawlinson TA, Henrici R, Charleston JA, Diez Benavente E, et al. Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research. eLife. 2019;8. Epub 2019/06/18. https://doi.org/10.7554/eLife.45829 PMID: 31205002; PubMed Central PMCID: PMC6579517.

47. Rawlinson TA, Barber NM, Mohring F, Cho JS, Kosaisavee V, Gerard SF, et al. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody. Nat Microbiol. 2019; 4(9):1497–507. Epub 2019/05/28. https://doi.org/10.1038/s41564-019-0462-1 PMID: 31133755; PubMed Central PMCID: PMC6711757.

48. Crosnier C, Wanaguru M, McDade B, Osier FH, Marsh K, Rayner JC, et al. A library of functional recombinant cell surface and secreted Plasmodium falciparum merozoite proteins. Molecular & cellular proteomics: MCP. 2013. Epub 2013/09/18. https://doi.org/10.1074/mcp.O113.028357 PMID: 24043421.

49. Bustamante LY, Bartholdson SJ, Crosnier C, Campos MG, Wanaguru M, Nguon C, et al. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants. Vaccine. 2013; 31(2):373–9. Epub 2012/11/14. https://doi.org/10.1016/j.vaccine.2012.10.106 PMID: 23146673; PubMed Central PMCID: PMC3538003.

50. Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2008; 46(2):165–71. Epub 2008/01/04. https://doi.org/10.1086/524888 PMID: 18171245; PubMed Central PMCID: PMC2533694.

51. Douglas AD, Williams AR, Illingworth JJ, Kamuyu G, Biswas S, Goodman AL, et al. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun. 2011; 2:601. Epub 2011/12/22. https://doi.org/10.1038/ncomms1615 PMID: 22186897.

52. Douglas AD, Baldeviano GC, Lucas CM, Lugo-Roman LA, Crosnier C, Bartholdson SJ, et al. A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys. Cell host & microbe. 2015; 17(1):130–9. https://doi.org/10.1016/j.chom.2014.11.017 PMID: 25590760; PubMed Central PMCID: PMC4297294.

53. Payne RO, Silk SE, Elias SC, Miura K, Diouf A, Galaway F, et al. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. JCI Insight. 2017; 2(21). Epub 2017/11/03. https://doi.org/10.1172/jci.insight.96381 PMID: 29093263; PubMed Central PMCID: PMC5752323.

54. Singh AP, Ozwara H, Kocken CH, Puri SK, Thomas AW, Chitnis CE. Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion. Molecular microbiology. 2005; 55(6):1925–34. Epub 2005/03/09. https://doi.org/10.1111/j.1365-2958.2005.04523.x PMID: 15752210.
55. Vermeulen AN, Roeffen WF, Henderik JB, Ponnudurai T, Beckers PJ, Meuwissen JH. Plasmodium falciparum transmission blocking monoclonal antibodies recognize monovalently expressed epitopes. *Dev Biol Stand*. 1985; 62:91-7. Epub 1985/01/01. PMID: 2422080.

56. Quakyi IA, Carter R, Rener J, Kumar N, Good MF, Miller LH. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. *J Immunol*. 1987; 139 (12):4213-7. Epub 1987/12/15. PMID: 2447164.

57. Kapulu MC, Da DF, Miura K, Li Y, Blagborough AM, Churcher TS, et al. Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum. *Scientific reports*. 2015; 5:11193. Epub 2015/06/13. https://doi.org/10.1038/srep11193 PMID: 26063320; PubMed Central PMCID: PMC4463016.

58. Taechalertpaisarn T, Crosnier C, Bartholdson SJ, Hodder AN, Thompson J, Bustamante LY, et al. Biochemical and functional analysis of two Plasmodium falciparum blood-stage 6-cys proteins: P12 and P41. *PloS one*. 2012; 7(7):e41937. Epub 2012/08/01. https://doi.org/10.1371/journal.pone.0041937 PMID: 22848665; PubMed Central PMCID: PMC3407074.

59. Franca CT, Hostetler JB, Sharma S, White MT, Lin E, Kiniboro B, et al. An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection. *PLoS neglected tropical diseases*. 2016; 10(5):e0004639. Epub 2016/05/18. https://doi.org/10.1371/journal.pntd.0004639 PMID: 27182597; PubMed Central PMCID: PMC4868274.

60. Franca CT, White MT, He WQ, Hostetler JB, Brewster J, Frato G, et al. Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development. *eLife*. 2017;6. Epub 2017/09/28. https://doi.org/10.7554/eLife.28673 PMID: 28949293; PubMed Central PMCID: PMC5655538.

61. Longley RJ, Franca CT, White MT, Kumpitak C, Sa-Angchai P, Gruszczyk J, et al. Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand. *Malaria journal*. 2017; 16(1):178. Epub 2017/04/30. https://doi.org/10.1186/s12936-017-1826-8 PMID: 28454546; PubMed Central PMCID: PMC5410030.

62. Li J, Ito D, Chen JH, Lu F, Cheng Y, Wang B, et al. Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to the merozoite rhoptry. *Parasitology international*. 2012; 61(3):443-9. Epub 2012/03/08. https://doi.org/10.1016/j.parint.2012.02.008 PMID: 22394409.

63. Wickramarachchi T, Devi YS, Mohmmed A, Chauhan VS. Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion. *PloS one*. 2008; 3(3):e1732. Epub 2008/03/06. https://doi.org/10.1371/journal.pone.0001732 PMID: 18320051; PubMed Central PMCID: PMC2253826.

64. Moreno-Perez DA, Saldarriaga A, Patarroyo MA. Characterizing PvARP, a novel Plasmodium vivax antigen. *Malaria journal*. 2013; 12:165. Epub 2013/05/22. https://doi.org/10.1186/1475-2875-12-165 PMID: 23688042; PubMed Central PMCID: PMC3662610.

65. Muh F, Ahmed MA, Han JH, Nyunt MH, Lee SK, Lau YL, et al. Cross-species analysis of apical asparagine-rich protein of Plasmodium vivax and Plasmodium knowlesi. *Scientific reports*. 2018; 8(1):5781. Epub 2018/04/11. https://doi.org/10.1038/s41598-018-23728-1 PMID: 29636493; PubMed Central PMCID: PMC5893618.

66. Arumugam TU, Takeo S, Yamasaki T, Thonkukiatkul A, Miura K, Otsuki H, et al. Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. *Infection and immunity*. 2011; 79(11):4523-32. Epub 2011/09/08. https://doi.org/10.1128/IAI.05412-11 PMID: 21896773; PubMed Central PMCID: PMC3257921.

67. Hinds L, Green JL, Knuepfer E, Grainger M, Holder AA. Novel putative glycosylphosphatidylinositol-anchored micronemal antigen of Plasmodium falciparum that binds to erythrocytes. *Eukaryotic cell*. 2009; 8(12):1869-79. Epub 2009/10/13. https://doi.org/10.1128/EC.00218-09 PMID: 19820120; PubMed Central PMCID: PMC2794214.

68. Changrob S, Han JH, Ha KS, Park WS, Hong SH, Chootong P, et al. Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure. *Malaria journal*. 2017; 16(1):348. Epub 2017/08/24. https://doi.org/10.1186/s12936-017-1967-9 PMID: 28830553; PubMed Central PMCID: PMC5568145.

69. Tsuboi T, Kappe SH, al-Yaman F, Prickett MD, Alpers M, Adams JH. Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein. *Infection and immunity*. 1994; 62 (12):5581-6. Epub 1994/12/01. https://doi.org/10.1128/IAI.62.12.5581-5586.1994 PMID: 7960140; PubMed Central PMCID: PMC303305.

70. Cole-Tobian JL, Michon P, Biasor M, Richards JS, Beeson JG, Mueller I, et al. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children. *Infection and immunity*. 2009; 77 (9):4009-17. Epub 2009/07/01. https://doi.org/10.1128/IAI.00158-09 PMID: 19564376; PubMed Central PMCID: PMC2737995.
55. Vermeulen AN, Roeffen WF, Henderik JB, Ponnudurai T, Beckers PJ, Meuwissen JH. Plasmodium falciparum transmission blocking monoclonal antibodies recognize monovalently expressed epitopes. *Dev Biol Stand*. 1985; 62:91-7. Epub 1985/01/01. PMID: 2422080.

56. Quakyi IA, Carter R, Rener J, Kumar N, Good MF, Miller LH. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. *J Immunol*. 1987; 139 (12):4213-7. Epub 1987/12/15. PMID: 2447164.

57. Kapulu MC, Da DF, Miura K, Li Y, Blagborough AM, Churcher TS, et al. Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum. *Scientific reports*. 2015; 5:11193. Epub 2015/06/13. https://doi.org/10.1038/srep11193 PMID: 26063320; PubMed Central PMCID: PMC4463016.

58. Taechalertpaisarn T, Crosnier C, Bartholdson SJ, Hodder AN, Thompson J, Bustamante LY, et al. Biochemical and functional analysis of two Plasmodium falciparum blood-stage 6-cys proteins: P12 and P41. *PloS one*. 2012; 7(7):e41937. Epub 2012/08/01. https://doi.org/10.1371/journal.pone.0041937 PMID: 22848665; PubMed Central PMCID: PMC3407074.

59. Franca CT, Hostetler JB, Sharma S, White MT, Lin E, Kiniboro B, et al. An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection. *PLoS neglected tropical diseases*. 2016; 10(5):e0004639. Epub 2016/05/18. https://doi.org/10.1371/journal.pntd.0004639 PMID: 27182597; PubMed Central PMCID: PMC4868274.

60. Franca CT, White MT, He WQ, Hostetler JB, Brewster J, Frato G, et al. Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development. *eLife*. 2017;6. Epub 2017/09/28. https://doi.org/10.7554/eLife.28673 PMID: 28949293; PubMed Central PMCID: PMC5655538.

61. Longley RJ, Franca CT, White MT, Kumpitak C, Sa-Angchai P, Gruszczyk J, et al. Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand. *Malaria journal*. 2017; 16(1):178. Epub 2017/04/30. https://doi.org/10.1186/s12936-017-1826-8 PMID: 28454546; PubMed Central PMCID: PMC5410030.

62. Li J, Ito D, Chen JH, Lu F, Cheng Y, Wang B, et al. Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to the merozoite rhoptry. *Parasitology international*. 2012; 61(3):443-9. Epub 2012/03/08. https://doi.org/10.1016/j.parint.2012.02.008 PMID: 22394409.

63. Wickramarachchi T, Devi YS, Mohmmed A, Chauhan VS. Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion. *PloS one*. 2008; 3(3):e1732. Epub 2008/03/06. https://doi.org/10.1371/journal.pone.0001732 PMID: 18320051; PubMed Central PMCID: PMC2253826.

64. Moreno-Perez DA, Saldarriaga A, Patarroyo MA. Characterizing PvARP, a novel Plasmodium vivax antigen. *Malaria journal*. 2013; 12:165. Epub 2013/05/22. https://doi.org/10.1186/1475-2875-12-165 PMID: 23688042; PubMed Central PMCID: PMC3662610.

65. Muh F, Ahmed MA, Han JH, Nyunt MH, Lee SK, Lau YL, et al. Cross-species analysis of apical asparagine-rich protein of Plasmodium vivax and Plasmodium knowlesi. *Scientific reports*. 2018; 8(1):5781. Epub 2018/04/11. https://doi.org/10.1038/s41598-018-23728-1 PMID: 29636493; PubMed Central PMCID: PMC5893618.

66. Arumugam TU, Takeo S, Yamasaki T, Thonkukiatkul A, Miura K, Otsuki H, et al. Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. *Infection and immunity*. 2011; 79(11):4523-32. Epub 2011/09/08. https://doi.org/10.1128/IAI.05412-11 PMID: 21896773; PubMed Central PMCID: PMC3257921.

67. Hinds L, Green JL, Knuepfer E, Grainger M, Holder AA. Novel putative glycosylphosphatidylinositol-anchored micronemal antigen of Plasmodium falciparum that binds to erythrocytes. *Eukaryotic cell*. 2009; 8(12):1869-79. Epub 2009/10/13. https://doi.org/10.1128/EC.00218-09 PMID: 19820120; PubMed Central PMCID: PMC2794214.

68. Changrob S, Han JH, Ha KS, Park WS, Hong SH, Chootong P, et al. Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure. *Malaria journal*. 2017; 16(1):348. Epub 2017/08/24. https://doi.org/10.1186/s12936-017-1967-9 PMID: 28830553; PubMed Central PMCID: PMC5568145.

69. Tsuboi T, Kappe SH, al-Yaman F, Prickett MD, Alpers M, Adams JH. Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein. *Infection and immunity*. 1994; 62 (12):5581-6. Epub 1994/12/01. https://doi.org/10.1128/IAI.62.12.5581-5586.1994 PMID: 7960140; PubMed Central PMCID: PMC303305.

70. Cole-Tobian JL, Michon P, Biasor M, Richards JS, Beeson JG, Mueller I, et al. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children. *Infection and immunity*. 2009; 77 (9):4009-17. Epub 2009/07/01. https://doi.org/10.1128/IAI.00158-09 PMID: 19564376; PubMed Central PMCID: PMC2737995.
71. Sampath S, Carrico C, Janes J, Gurumoorthy S, Gibson C, Melcher M, et al. Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development. PLoS Pathog. 2013; 9(6):e1003420. Epub 2013/07/16. https://doi.org/10.1371/journal.ppat.1003420 PMID: 23853575; PubMed Central PMCID: PMC3681752.

72. George MT, Schloegel JL, Ntumngia FB, Barnes SJ, King CL, Casey JL, et al. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain. mSphere. 2019; 4(3). Epub 2019/05/17. https://doi.org/10.1128/mSphere.00194-19 PMID: 31092602; PubMed Central PMCID: PMC6520440.

73. Urusova D, Carías L, Huang Y, Nicolete VC, Popovici J, Roesch C, et al. Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP. Nat Microbiol. 2019; 4(9):1486-96. Epub 2019/05/28. https://doi.org/10.1038/s41564-019-0461-2 PMID: 31133752; PubMed Central PMCID: PMC6707876.

74. Jiang L, Gaur D, Mu J, Zhou H, Long CA, Miller LH. Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(18):7553-8. Epub 2011/04/20. https://doi.org/10.1073/pnas.1104050108 PMID: 21502513; PubMed Central PMCID: PMC3088598.

75. Healer J, Thompson JK, Riglar DT, Wilson DW, Chiu YH, Miura K, et al. Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum. PloS one. 2013; 8(9):e72504. Epub 2013/09/17. https://doi.org/10.1371/journal.pone.0072504 PMID: 24039774; PubMed Central PMCID: PMC3769340.

76. Duraisingh MT, Maier AG, Triglia T, Cowman AF. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(8):4796-801. Epub 2003/04/04. https://doi.org/10.1073/pnas.0730883100 PMID: 12672957; PubMed Central PMCID: PMC153635.

77. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, Duraisingh MT, et al. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science (New York, NY. 2005; 309(5739):1384-7. https://doi.org/10.1126/science.1115257 PMID: 16123303.

78. Verzier LH, Coyle R, Singh S, Sanderson T, Rayner JC. Plasmodium knowlesi as a model system for characterising Plasmodium vivax drug resistance candidate genes. PLoS neglected tropical diseases. 2019; 13(6):e0007470. Epub 2019/06/04. https://doi.org/10.1371/journal.pntd.0007470 PMID: 31158222; PubMed Central PMCID: PMC6564043.

79. Dreyer AM, Matile H, Papastogiannidis P, Kamber J, Favuzza P, Voss TS, et al. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen. J Immunol. 2012; 188(12):6225-37. https://doi.org/10.4049/jimmunol.1103177 PMID: 22593616.

80. Jones ML, Kitson EL, Rayner JC. Plasmodium falciparum erythrocyte invasion: a conserved myosin associated complex. Molecular and biochemical parasitology. 2006; 147(1):74-84. https://doi.org/10.1016/j.molbiopara.2006.01.009 PMID: 16513191.

81. Blackman MJ, Dennis ED, Hirst EM, Kocken CH, Scott-Finnigan TJ, Thomas AW. Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1. Exp Parasitol. 1996; 83(2):229-39. Epub 1996/07/01. https://doi.org/10.1006/expr.1996.0069 PMID: 8682191.

82. Theron M, Cross N, Cawkill P, Bustamante LY, Rayner JC. An in vitro erythrocyte preference assay reveals that Plasmodium falciparum parasites prefer Type O over Type A erythrocytes. Scientific reports. 2018; 8(1):8133. Epub 2018/05/29. https://doi.org/10.1038/s41598-018-26559-2 PMID: 29802282; PubMed Central PMCID: PMC5970199.

83. seaborn: statistical data visualization—seaborn 0.11.0 documentation Available from: https://seaborn.pydata.org/.

84. Hunter JD. Matplotlib: A 2D Graphics Environment. Computing in Science & Engineering. 2007;9. https://doi.org/10.1109/MCSE.2007.55

85. McKinney W. Data Structures for Statistical Computing in Python. 9th Python in Science Conference2010.

86. Weber M. statannot.

87. Seabold S, Perktold, J. Statsmodels: Econometric and Statistical Modeling with Python. 9th Python in Science Conference2010.

88. Benchling: Cloud-Based Informatics Platform for Life Sciences R&D. Available from: https://www.benchling.com/.

89. CRISPR gRNA (guide RNA) Design Tool for Eukaryotic Pathogens Available from: http://grna.ctegd.uga.edu/.
71. Sampath S, Carrico C, Janes J, Gurumoorthy S, Gibson C, Melcher M, et al. Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development. PLoS Pathog. 2013; 9(6):e1003420. Epub 2013/07/16. https://doi.org/10.1371/journal.ppat.1003420 PMID: 23853575; PubMed Central PMCID: PMC3681752.

72. George MT, Schloegel JL, Ntumngia FB, Barnes SJ, King CL, Casey JL, et al. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain. mSphere. 2019; 4(3). Epub 2019/05/17. https://doi.org/10.1128/mSphere.00194-19 PMID: 31092602; PubMed Central PMCID: PMC6520440.

73. Urusova D, Carías L, Huang Y, Nicolete VC, Popovici J, Roesch C, et al. Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP. Nat Microbiol. 2019; 4(9):1486-96. Epub 2019/05/28. https://doi.org/10.1038/s41564-019-0461-2 PMID: 31133752; PubMed Central PMCID: PMC6707876.

74. Jiang L, Gaur D, Mu J, Zhou H, Long CA, Miller LH. Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(18):7553-8. Epub 2011/04/20. https://doi.org/10.1073/pnas.1104050108 PMID: 21502513; PubMed Central PMCID: PMC3088598.

75. Healer J, Thompson JK, Riglar DT, Wilson DW, Chiu YH, Miura K, et al. Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum. PloS one. 2013; 8(9):e72504. Epub 2013/09/17. https://doi.org/10.1371/journal.pone.0072504 PMID: 24039774; PubMed Central PMCID: PMC3769340.

76. Duraisingh MT, Maier AG, Triglia T, Cowman AF. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(8):4796-801. Epub 2003/04/04. https://doi.org/10.1073/pnas.0730883100 PMID: 12672957; PubMed Central PMCID: PMC153635.

77. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, Duraisingh MT, et al. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science (New York, NY. 2005; 309(5739):1384-7. https://doi.org/10.1126/science.1115257 PMID: 16123303.

78. Verzier LH, Coyle R, Singh S, Sanderson T, Rayner JC. Plasmodium knowlesi as a model system for characterising Plasmodium vivax drug resistance candidate genes. PLoS neglected tropical diseases. 2019; 13(6):e0007470. Epub 2019/06/04. https://doi.org/10.1371/journal.pntd.0007470 PMID: 31158222; PubMed Central PMCID: PMC6564043.

79. Dreyer AM, Matile H, Papastogiannidis P, Kamber J, Favuzza P, Voss TS, et al. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen. J Immunol. 2012; 188(12):6225-37. https://doi.org/10.4049/jimmunol.1103177 PMID: 22593616.

80. Jones ML, Kitson EL, Rayner JC. Plasmodium falciparum erythrocyte invasion: a conserved myosin associated complex. Molecular and biochemical parasitology. 2006; 147(1):74-84. https://doi.org/10.1016/j.molbiopara.2006.01.009 PMID: 16513191.

81. Blackman MJ, Dennis ED, Hirst EM, Kocken CH, Scott-Finnigan TJ, Thomas AW. Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1. Exp Parasitol. 1996; 83(2):229-39. Epub 1996/07/01. https://doi.org/10.1006/expr.1996.0069 PMID: 8682191.

82. Theron M, Cross N, Cawkill P, Bustamante LY, Rayner JC. An in vitro erythrocyte preference assay reveals that Plasmodium falciparum parasites prefer Type O over Type A erythrocytes. Scientific reports. 2018; 8(1):8133. Epub 2018/05/29. https://doi.org/10.1038/s41598-018-26559-2 PMID: 29802282; PubMed Central PMCID: PMC5970199.

83. seaborn: statistical data visualization—seaborn 0.11.0 documentation Available from: https://seaborn.pydata.org/.

84. Hunter JD. Matplotlib: A 2D Graphics Environment. Computing in Science & Engineering. 2007;9. https://doi.org/10.1109/MCSE.2007.55

85. McKinney W. Data Structures for Statistical Computing in Python. 9th Python in Science Conference2010.

86. Weber M. statannot.

87. Seabold S, Perktold, J. Statsmodels: Econometric and Statistical Modeling with Python. 9th Python in Science Conference2010.

88. Benchling: Cloud-Based Informatics Platform for Life Sciences R&D. Available from: https://www.benchling.com/.

89. CRISPR gRNA (guide RNA) Design Tool for Eukaryotic Pathogens Available from: http://grna.ctegd.uga.edu/.
90. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nature methods. 2012; 9 (4):357–9. Epub 2012/03/06. https://doi.org/10.1038/nmeth.1923 PMID: 22388286; PubMed Central PMCID: PMC3322381.

91. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078–9. Epub 2009/06/10. https://doi.org/10.1093/bioinformatics/btp352 PMID: 19505943; PubMed Central PMCID: PMC2723002.

92. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nature biotechnology. 2011; 29(1):24–6. Epub 2011/01/12. https://doi.org/10.1038/nbt.1754 PMID: 21221095; PubMed Central PMCID: PMC3346182.

93. Bioinformatics and Functional Genomics, 2nd Edition. Available from: http://bioinfbook.org/php/?q=book2.

94. Wickham H. ggplot2: Elegant Graphics for Data Analysis

95. ggpubr package | R Documentation.

96. Streamlined Plot Theme and Plot Annotations for "ggplot2"

97. A Forward-Pipe Operator for R.

98. Read Excel Files

99. dplyr: A Grammar of Data Manipulation version 1.0.0 from CRAN
90. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nature methods. 2012; 9 (4):357–9. Epub 2012/03/06. https://doi.org/10.1038/nmeth.1923 PMID: 22388286; PubMed Central PMCID: PMC3322381.

91. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078–9. Epub 2009/06/10. https://doi.org/10.1093/bioinformatics/btp352 PMID: 19505943; PubMed Central PMCID: PMC2723002.

92. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nature biotechnology. 2011; 29(1):24–6. Epub 2011/01/12. https://doi.org/10.1038/nbt.1754 PMID: 21221095; PubMed Central PMCID: PMC3346182.

93. Bioinformatics and Functional Genomics, 2nd Edition. Available from: http://bioinfbook.org/php/?q=book2.

94. Wickham H. ggplot2: Elegant Graphics for Data Analysis

95. ggpubr package | R Documentation.

96. Streamlined Plot Theme and Plot Annotations for "ggplot2"

97. A Forward-Pipe Operator for R.

98. Read Excel Files

99. dplyr: A Grammar of Data Manipulation version 1.0.0 from CRAN